Point72 Hong Kong’s BioLife Solutions BLFS Stock Holding History

Point72 Hong Kong’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,592	Closed	-$36K	–	1933
2022 Q1	$36K	Buy	+1,592	New	+$41.9K	﹤0.01%	1419

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Point72 Hong Kong's BLFS Position: Q2 2022 in Review

Point72 Hong Kong sold out of BioLife Solutions (BLFS) in Q2 2022, closing a stake of 1,592 shares — an estimated $36K sold.

Point72 Hong Kong first reported a position in BLFS in Q1 2022 and held it in 1 quarter. The position peaked at $36K in Q1 2022. 160 funds tracked by Wall St. Rank hold BLFS as of Q2 2022.

Point72 Hong Kong reported no remaining BioLife Solutions position as of Q2 2022 after selling out during the quarter.
Point72 Hong Kong sold 1,592 BioLife Solutions shares in Q2 2022, an estimated $36K.
Point72 Hong Kong first reported a position in BioLife Solutions in Q1 2022 and held it in 1 quarter.
Point72 Hong Kong's BioLife Solutions position peaked at $36K in Q1 2022.
160 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.